CURE® Magazine to Host #CureConnect TweetChat on Immunotherapy
June 25 2018 - 8:46AM
Business Wire
CURE Media Group’s flagship product, CURE® magazine, the
nation’s leading consumer digital and print media enterprise
focusing on patients with cancer, will be hosting its monthly
TweetChat on Wednesday, June 27, at 1 p.m. EDT, for readers to ask
questions and to facilitate discussions about the recent specialty
issue on immunotherapy.
“We’re looking forward to the next edition of #CureConnect
TweetChat that will discuss patients’ stories and experiences with
immunotherapy. We hope you can all join us,” said Michael J.
Hennessy Jr, president of MJH Associates, parent company of
CURE®.
CURE® welcomes all patients and their loved ones, as well as
health care professionals, advocates and nonprofit organizations to
join the chat by using the hashtag #CureConnect. The below
highlights from the special issue will lead the discussion:
- The Jury Is Out: Checkpoint inhibitors
can be extremely effective for the right patients, but identifying
who will benefit remains an imprecise science;
- Under New Management: a new expert
guideline for managing the side effects of checkpoint inhibitors
has been released;
- Contagious Enthusiasm: Oncolytic, or
engineered, viruses are emerging as promising delivery systems for
cancer-killing drugs;
- And more.
For more information, visit https://www.curetoday.com or find us
on Twitter (@cure_magazine) or on
Facebook (@curemagazine).
About CURE Media Group
CURE Media Group is the leading resource for cancer updates,
research and education. It combines a full suite of media products,
including its industry-leading website, CUREtoday.com; innovative
video programs, such as CURE Connections®; a series of widely
attended live events; and CURE® magazine, which reaches over 1
million readers. CURE Media Group is part of the Cranbury, New
Jersey-based MJH Associates Inc. family of businesses, which
includes the acclaimed OncLive® (http://www.www.onclive.com)
platform of resources for the practicing oncologist. For more
information, visit http://www.curetoday.com or
http://www.mjhassoc.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180625005701/en/
CURE Media Group press:Theresa Burek,
609-325-4811tburek@mjhassoc.com